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Abstract
Background: Therapist-supported, internet-delivered cognitive behavioral therapy (iCBT) is efficient in the treatment of
depression. However, the optimal mode and intensity of therapist support remain to be identified. Scheduled telephone support
(STS) may improve adherence and outcomes but, as it is time- and resource-consuming, should be reserved for patients for whom
the usual support may be insufficient.
Objective: This paper aims to reveal whether add-on STS for patients at risk of dropping out improves treatment adherence
and symptoms in iCBT for depression.
Methods: Among patients participating in an ongoing large observational routine clinical practice study of iCBT for depression
delivered nationwide by Helsinki University Hospital (HUS-iCBT), those demonstrating a ≥14-day delay in initiation of treatment
received invitations to this subsidiary STS study. A total of 100 consenting patients were randomly allocated to either HUS-iCBT
as usual (control group, n=50) or HUS-iCBT plus add-on STS (intervention group, n=50). Proportions of those reaching
midtreatment and treatment end point served as the primary outcome; secondary outcomes were change in Beck Depression
Inventory (BDI)–measured depressive symptoms and time spent in treatment.
Results: Add-on STS raised the proportion of patients reaching midtreatment compared with HUS-iCBT as usual (29/50, 58%
vs 18/50, 36%; P=.045) and treatment end point (12/50, 24% vs 3/50, 6%; P=.02). Change in BDI score also favored add-on STS
(3.63 points vs 1.1 points; P=.049), whereas duration of treatment did not differ.
Conclusions: Add-on STS enhances adherence and symptom improvement of patients at risk of dropping out of iCBT for
depression in routine clinical practice.
Trial Registration: International Standard Randomised Controlled Trial Number (ISRCTN) 55123131;
http://www.isrctn.com/ISRCTN55123131.
(J Med Internet Res 2020;22(7):e15732) doi: 10.2196/15732
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Introduction
Despite the growing burden of mental health disorders, treatment
is available for fewer than half of those in need [1]. Among
mental health conditions, depressive disorders are some of the
most prevalent [2]. As a leading cause of disability worldwide
[3], they represent a major burden for health care systems [4].
For depressive disorders, recommended first-line treatments
include psychological interventions, specifically psychotherapies
[5]. Although psychotherapies are highly acceptable among
clients [6,7], their availability is limited [8]. Some of the main
challenges are shortage of professionals, perceived stigma, cost,
and long distance to services [9].
Computer-based delivery of psychotherapy improves access to
psychological treatments of depression [10]. Internet-delivered
cognitive behavioral therapy (iCBT) entails modules or lessons
delivering cognitive behavioral therapy (CBT) concepts via the
internet [11]. iCBT for depression offers solutions to such
challenges as poor treatment availability, fidelity and
affordability, and constraints of location and time [10,12]. In
randomized controlled trials (RCTs), iCBT for depression
demonstrates efficacy equal to that of traditional face-to-face
CBT but only if accompanied by therapist support [11,13,14],
wherein the program involves therapist guidance, typically via
email [15]. Fully automated iCBT treatments, supported by only
computerized reminders, tend to be less efficacious than the
ones with therapist guidance [16,17].
High variation in attrition rates indicates that in some iCBT
studies, a considerable number of patients fail to complete the
treatment even in therapist-supported programs [18]. In a review
comprising 19 studies on iCBT with therapist support for various
mental disorders, the dropout (defined as termination at any
point between registering for treatment and completing
follow-up questionnaires) ranged from 2% to 83%, with a
weighted average of 31% [19]. Two reviews of RCTs for
therapist-supported iCBTs have shown a dropout rate of
approximately 20% [10,20] and one meta-analysis on iCBT for
depression showed a mean dropout rate of 28% [21]. However,
in a large routine clinical practice study of a primary care
population, 82% of participants failed to finish the program
[22].
A meta-analysis of iCBT studies [19] identified several potential
predictors of attrition, including age, gender, socioeconomic
and relationship status, duration and target of the psychological
problem, comorbidity, client-related psychological variables,
treatment credibility, computer experience, motivation, the type
of support medium, and quality and duration of clinician contact.
Research evidence on these variables is, so far, limited. Adding
fees, choice, reminders, and clinician support seems to
strengthen adherence [23]. The essential elements of the contact
are, however, debatable. Eysenbach [18] hypothesized that
dropout is more likely the more “virtual” the support is.
Synchronous telephone contact may be less virtual than is
support in writing. Thus far, to our knowledge, no meta-analysis
has yet directly investigated the impact of the contact medium
used in iCBT for depression [24].
Telephone calls offering technical assistance facilitated
self-monitoring during a web-based intervention versus only
automated assistance [25]. Automated but personalized
telephone prompts were useful for maintaining adherence in a
study on weight control intervention [26]. However, in iCBT
for depression, weekly telephone calls by a lay telephone
counsellor did not confer additional advantage for callers to a
helpline service [27]. The researchers proposed that more
benefits might be achieved with support provided by a clinician.
Nevertheless, therapist-delivered telephone and email support
in iCBT for depression did not yield improvement in outcomes
or in dropout rates [24]. Neither did technician-delivered
telephone support demonstrate advantages over a
clinician-moderated online discussion forum in iCBT for social
phobia [28], although in the same program, telephone calls
facilitated symptomatic improvement and adherence versus
automatic reminders only [29]. In an iCBT aftercare program
for bulimia nervosa, telephone prompts by a research assistant
improved adherence [30], as did telephone support by a
technician in iCBT for depression in primary care compared
with text-based support [31]. Furthermore, in a trial of patients
with treatment-resistant obsessive-compulsive disorder (OCD),
scheduled telephone support (STS) reduced dropout rate
compared with optional telephone support [32].
Even though STS has improved adherence, it consumes more
resources than iCBT as usual and the target group therefore
needs careful defining. Several potential factors predict dropout
[19], but to the best of our knowledge, no clear-cut criteria for
identification of increased dropout risk exist, and no trials have
directly studied the effects of extra support in iCBT for
depression to aid patients at such risk.
This RCT investigated whether STS added to iCBT as usual
enhanced adherence to and effectiveness of iCBT for depression
in a sample of patients at high risk for dropping out, (ie, those
demonstrating delayed start of iCBT).
We expected that the add-on STS would enhance adherence to
treatment, reduce symptoms of depression, and shorten the
duration of treatment in patients at risk for dropping out.
Methods
HUS-iCBT as Usual
The department of psychiatry of Helsinki University Hospital
(HUS) has developed and is providing nationwide a range of
original Finnish-language iCBT programs (further referred to
as HUS-iCBTs) for common psychiatric disorders to which all
physicians licensed in Finland can refer patients. To receive
HUS-iCBT for depression, patients must be diagnosed with a
depressive episode (code F32-F33 in International Classification
of Diseases 10) and be aged ≥18 years. Exclusion criteria are
current alcohol misuse as judged by the referring physician;
known diagnosis of schizophrenia or other psychotic disorder,
bipolar disorder, serious personality disorder, or neurological
or neuropsychiatric disorder that adversely affects the patient’s
cognitive performance; or demonstrated, reported, or observed
suicidal intentions. However, each referring physician holds
primary judicial responsibility for overall treatment and, prior
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to referral, verifies the diagnosis and checks all of these criteria.
No pretreatment interview by the therapy provider is thus
necessary.
The HUS-iCBT for depression consists of 7 consecutive
modules and is 109 pages in total, including texts, videos,
illustrations, and assignments. Contents include information on
depression and CBT, goal definition, behavioral activation,
cognitive restructuring, advice on a balanced life, relapse
prevention, and homework. Patients use a secure online identity
system to enter the program. They are required to report possible
suicidal thoughts. The time schedule of the treatment is flexible,
although patients are prompted to progress at a pace of 1 module
per week. Active engagement is required, since progress to the
next module is prevented if any of the previous module
assignments is not completed.
The program sends email prompts for new messages and login
reminders. The same internet therapist follows each patient
throughout the treatment, and they communicate asynchronously
via text-based message board within the therapy program. The
therapist sends messages in the beginning, at midtreatment, at
the sixth module, and at the end point; patients receive
encouragement to write to the therapist any time with their
questions or concerns. The therapist comments on the completed
tasks, offering praise and support for the patient. The patients
receive automatic messages recapitulating the contents of the
modules, which are distinguished from the messages sent by
therapists. In addition, the patients receive an email prompt if
no login occurs for 2 weeks and when they receive a new
message. Automatic prompts notify therapists of new messages
or in case of any sign of suicidality. When expected progress
fails, the therapist tries to contact the patient by a message within
2 to 4 weeks. If the patient still does not appear in the program,
the therapist tries to reach the patient by telephone
(therapist-initiated telephone calls are not used for other
purposes). If the patient remains unreachable by telephone, a
letter on paper is sent to uncover the reason for no show.
Study Patients and Design
Large Simple Observational Study
All patients referred to the HUS-iCBT for depression are invited
to participate in an ongoing nationwide, low-threshold,
flexible–time schedule, observational, routine clinical care study
on the effectiveness of HUS-iCBT in depressive disorders
(original report under preparation). The only additional criterion
for that study is a signed informed consent. All consenting
patients (currently 79% of those accepted for the HUS-iCBT)
are eligible to participate and are enrolled into that study.
The STS Study
The current study was a subsidiary RCT branch of the
observational study described above. Patients participating in
the observational study received invitations to participate in the
STS study if they had not proceeded in the HUS-iCBT for ≥14
days after their first entry, a delay interpreted as increased risk
for dropping out. The patients were enrolled subsequently from
September 2015 to October 2016 until the number of participants
reached 100. These patients were randomly allocated to either
HUS-iCBT as usual plus add-on STS (add-on STS group, n=50)
or to HUS-iCBT as usual (control group, n=50) when a 14-day
delay was detected, either during or after completing the first
module of the treatment. The maximum time span allowed for
this study participation since initiation was 6 months.
Add-on STS Intervention
In addition to the standard HUS-iCBT, the add-on STS
intervention group received 8 weekly 15-minute telephone calls,
the first at the beginning of iCBT and the subsequent calls during
each of the 7 modules, without any further calls regardless of
patient progress. If necessary (eg, if a patient was reached in a
bad moment or asked the therapist to call again), new calls were
allowed, amounting to more than the intended 8 calls. During
the first call, selection of individual goals took place. The tasks
and themes of each module were discussed in the calls that
followed each module. Support was individually tailored and
followed the principles of the model of supportive accountability
[33], which combines elements of motivational theory,
organizational psychology, and computer-mediated
communication to create a framework for supported
computerized treatment. According to this model, combining
elements of support and accountability with a legitimized and
trustworthy relationship increases adherence. If delays occurred,
the prescheduled calls were generally not replaced, although
therapists had final judgement over this.
Therapists
All 5 therapists involved in this trial were clinical psychologists
employed by HUS and had at least 2 years of work experience
with depressed patients. They attended a 1-day training session
in HUS-iCBT on the study protocol of the above-mentioned
observational study and of the current STS study, the STS
methodology, and the International Council for Harmonisation
Good Clinical Practice (ICH-GCP) guidelines. Their role
included providing feedback on assignments and support with
any patient issues. Every 2 months, they participated in a group
supervision session, discussing any concerns or issues arising.
At any time, the therapists could consult a clinical psychologist
with advanced iCBT experience.
All 5 STS therapists were at the same time also providing regular
HUS-iCBT for other patients, and in this study, each treated
both add-on STS intervention and control groups. Study patients
were assigned to each therapist randomly, depending on that
therapist’s current workload, resulting in the 5 therapists having
35, 30, 18, 14, and 3 patients.
Outcome Measures
Primary outcome measures were proportion of patients reaching
midtreatment (third module) and end point (seventh module).
Secondary outcome measures were change (from start to
completion or to dropout, with last observation carried forward)
in Beck Depression Inventory (BDI) [34] scores and treatment
time (in days) from start to end point (or premature
discontinuation). The internet-administered BDI has good
psychometric properties [35]. The patients completed it online
at the beginning, midtreatment, and end point.
At enrollment, all patients completed 6 demographic questions.
The rest of the demographic data were collected from the
J Med Internet Res 2020 | vol. 22 | iss. 7 | e15732 | p. 3http://www.jmir.org/2020/7/e15732/
(page number not for citation purposes)
Pihlaja et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
referrals. The therapists recorded the number and duration of
telephone calls. The experienced usefulness was recorded at the
end of each module by visual analog scale, where “not at all
useful” equaled 0 and “very useful” equaled 10.
Ethics and Legislation
The study followed the ICH-GCP and Finnish national
regulations. The study protocol was approved by the Ethics
Committee of HUS and by pertinent institutional authorities.
After reading a complete description of the study, the patients
provided informed consent electronically. The trial was
registered at the International Standard Randomised Controlled
Trial Number (ISRCTN) registry (ISRCTN55123131).
Statistical Analyses
Primary analyses, based on the intention-to-treat principle,
included all patients. Analysis of variance and chi-square tests
served to reveal group differences in baseline characteristics
and in dropout rates.
Group comparisons of patients reaching midtreatment and end
point employed chi-square tests. Cox regression survival
analysis served to determine group differences in survival
probabilities (ie, time spent in treatment before dropping out
during the 6-month time period). This analysis was adjusted for
experienced session usefulness at the end of the first session,
measured by visual analog scale. The Mann-Whitney test served
for group comparisons of change in depression (BDI scores)
from baseline to last observation carried forward and treatment
length (in days).
Statistical analyses employed SPSS Statistics (version 25; IBM
Corp) for Windows (Microsoft Corp).
Results
Baseline Characteristics
Analyses comprised 50 patients in the add-on STS group and
50 patients in the control group (see Figure 1).
Figure 1. Scheduled telephone support in iCBT for depression: patient flow diagram. HUS-iCBT: Helsinki University Hospital internet-based cognitive
behavioral therapy programs; iCBT: internet-delivered cognitive behavioral therapy; RCT: randomized controlled trial; STS: scheduled telephone
support.
Of 618 patients of the observational depression study, all 618
(100%) were invited to participate in the STS study, which
amounts to 77.0% of the 803 patients enrolled during the time
period between September 13, 2015, and October 5, 2016. Of
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the 618 invited, 576 patients (93.2%) agreed to participate. Of
these 576 patients, 476 (82.6%) did not show a 14-day delay in
beginning the treatment and were excluded on that criterion. A
total of 6 patients of the add-on STS group never received any
telephone calls (ie, did not receive the STS intervention).
No significant differences between groups emerged at baseline
(see Table 1). Some patients did not provide several baseline
demographic data (marital, educational, and employment
statuses and use of medication or sick leave within last 6
months). However, there was no association between missing
data and group membership. Interpretations of results concerning
primary and secondary outcomes remained the same after
controlling for an indicator of nonresponse to these demographic
questions.
Table 1. Baseline group characteristics.
P valuet testb (df)Chi-square (df)Total (n=100)Control (n=50)Add-on STSa (n=50)
.67N/Ac0.18 (1)66 (66.0)32 (64.0)34 (68.0)Female, n (%)
.26N/A6.50 (5)Referred from, n (%)
51 (51.0)23 (46.0)28 (56.0)Primary health care
26 (26.0)15 (30.0)11 (22.0)Private health care
9 (9.0)2 (4.0)7 (14.0)Occupational health care
7 (7.0)5 (10.0)2 (4.0)Student health care
4 (4.0)3 (6.0)1 (2.0)Specialized psychiatry
3 (3.0)2 (4.0)1 (2.0)Unspecified
.85N/A0.80 (3)Marital status, n (%)d
10 (35.7)4 (28.6)6 (42.9)Married
4 (14.3)2 (14.3)2 (14.3)Living together
10 (35.7)6 (42.9)4 (28.6)Not married
4 (14.3)2 (14.3)2 (14.3)Divorced
.85N/A0.80 (3)Educational level, n (%)d
3 (10.7)2 (14.3)1 (7.1)Elementary school
15 (53.6)7 (50.0)8 (57.1)Secondary/vocational
5 (17.9)2 (14.3)3 (21.4)College/university Bachelor
5 (17.9)3 (21.4)2 (14.3)College/university Master
.18N/A4.88 (3)Employment status, n (%)d
18 (64.3)7 (50.0)11 (78.6)Full time
1 (3.6)0 (0)1 (7.1)Part time
8 (28.6)6 (42.9)2 (14.3)Unemployed
1 (3.6)1 (7.1)0 (0)Retired
.69N/A0.16 (1)Medication, n (%)d
9 (32.1)4 (28.6)5 (35.7)None
19 (67.9)10 (71.4)9 (64.3)Presente
.26N/A129 (1)15 (53.6)6 (42.9)9 (64.3)Sick leave within 6 months, n (%)d
.271.11 (98)N/A36.11 (11.10)34.82 (10.99)37.40 (12.16)Age, mean (SD)
.301.04 (96)N/A22.41 (8.75)23.33 (10.04)21.49 (7.15)BDIf at baseline, mean (SD)
aSTS: scheduled telephone support.
b2-tailed t test.
cN/A: not applicable.
dInformation available for 14 patients in add-on STS intervention group and for 14 control group patients.
eAnxiolytic or antidepressant.
fBDI: Beck Depression Inventory.
J Med Internet Res 2020 | vol. 22 | iss. 7 | e15732 | p. 5http://www.jmir.org/2020/7/e15732/
(page number not for citation purposes)
Pihlaja et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Since there was a considerable amount of missing data in some
of the baseline characteristics, we performed comparisons (using
a 2-tailed t test) of depression at baseline (BDI score) between
patients that filled in (n=28) and did not fill in (n=72) a separate
questionnaire of demographics. There was no difference in
depression at baseline between the groups (t96=0.445; P=.66).
No adverse events, such as hospitalization or serious illness,
occurred during the study. Altogether, 44 of the 50 (88%)
patients in the add-on STS intervention group received the
previously scheduled telephone calls (versus a total of 5 patients
received optional calls in the control group), as seen in Table
2.
Patients in the add-on STS group reached an average of 3.54
modules, while patients in the control group reached an average
of 2.46 modules (see Table 3).
Table 2. Mean number and duration of telephone calls received.
Control (n=50)Add-on STSa (n=50)Telephone call characteristics
5 (10)44 (88)Proportion of patients who received calls, n (%)b
0.32 (0.99), 0-54.63 (3.58), 0-11Number of calls per patient, mean (SD), rangeb
6.20 (2.17)13.09 (5.25)Average duration of calls (minutes), mean (SD)b
1.95 (6.11), 0-3073.37 (48.95), 5-165Cumulative duration of calls (minutes), mean (SD), rangeb
55132Assessed average therapist time (minutes), nc
aSTS: scheduled telephone support.
bMissing values for 9 patients in each group.
cIn addition to contact time itself, STS takes approximately 4 more minutes for preparation of the call and additional documentation, resulting in a total
of 77 additional minutes for STS intervention vs HUS-iCBT as usual.
Table 3. Module reached by patients in each group during 6 months.
Last module reached, mean (SD)Module reached, n (%)
76543210
3.54 (2.57)13 (26)13 (26)19 (38)26 (52)28 (56)33 (66)45 (90)50 (100)Add-on STSa
2.46 (1.88)3 (6)4 (8)7 (14)15 (30)19 (38)27 (54)48 (96)50 (100)Control
aSTS: scheduled telephone support.
Outcomes
Adherence (Primary Outcome)
Of the 100 randomized patients, 21 of the 50 patients in the
add-on STS group (42%) and 32 of the 50 patients in the control
group (64%) dropped out by midtreatment. Corresponding
figures for the end point were 38 of 50 patients (76%) and 47
of 50 patients (94%). The proportion who reached midtreatment
and end point favored the add-on STS group significantly (Table
4). Cox regression survival analysis revealed no difference in
the timing of dropout between groups (survival curves χ²2=2.5,
P=.48; hazard ratio=1.29, 95% CI 0.64-2.61, P=0.48), as shown
in Figure 2.
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Figure 2. Cox regression survival curves for staying in treatment for the add-on STS and control groups at 6 months. STS: scheduled telephone support.
Secondary Outcomes
The BDI-measured change from baseline showed a statistically
significant difference also favoring the add-on STS group. This
result also remained when analyses were carried out using linear
mixed models, which handles missing values more efficiently
and without imputing the missing values (F2,30=3.77; P=.04).
No statistically significant differences emerged for days spent
on therapy (P=.67).
Table 4. Effects of add-on STS on adherence, depression, and time in treatment.
P valueMann-Whitney testChi-square (df)Control (n=50)Add-on STSa (n=50)Outcome
.045cN/A4.9 (1)18 (36)29 (58)Reached midtreatment, n (%)b
.02cN/A6.4 (1)3 (6)12 (24)Completed the program, n (%)b
.049c1455.5N/AfChange in BDId from baselinec,e
1.06 (4.82)3.63 (5.94)Change in BDI from baseline, mean (SD)
0 (0.0;1.0)0 (0.0;8.5)Change in BDI from baseline, median
(P25;P75)g
.671190.5N/ATreatment time in dayse
141.36 (48.08)136.61 (52.18)Treatment time (days), mean (SD)
161.5
(100.25;183.00)
166.95 (96.27;183.00)Treatment time (days), median (P25;P75)
aSTS: scheduled telephone support.
bPrimary outcome.
cLast observation carried forward.
dBDI: Beck Depression Inventory.
eSecondary outcome.
fN/A: not applicable.
g25th and 75th percentiles.
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Discussion
Principal Results
In patients at risk of dropout during iCBT for depression, add-on
STS yielded an increased proportion of patients reaching
midtreatment (29/50, 58% vs 18/50, 36%; P=.045) and
proportion of patients who completed treatment (12/50, 24%
vs 3/50, 6%; P=.02) compared with the control group. Moreover,
depressive symptoms decreased more for those with add-on
STS than with HUS-iCBT alone (mean change 3.63 vs 1.06;
P=.049), but the survival analysis did not reveal any statistically
significant differences in survival probabilities, that is, time
spent in treatment before dropping out (P=.67).
Comparison With Prior Work
Two other RCTs on STS have reported positive results. Notably,
both studies used iCBT with no text-based support, meaning
that comparison of our results with these previous reports should
be undertaken with caution.
Gilbody and coauthors [31] compared STS to iCBT with no
STS in primary care patients with depression, reporting
improvement in symptom change and a decrease in dropout rate
from 71% to 54% at midtreatment and from 90% to 81% at end
point in their STS group patients compared with their control
group patients with access only to a support helpline. Despite
the at-risk population in the current study, our figures seem
comparable (drop from 32/50, 64% to 21/50, 42% at
midtreatment and from 48/50, 96% to 38/50, 76% at end point).
Kenwright and colleagues [32], in their iCBT trial comparing
STS to patient-initiated calls, reported an STS-induced change
from 59% to 14% for early dropout rate and from 64% to 50%
for late dropout rate. Their patients, however, suffered not from
depression but from OCD. OCD is known to often be difficult
to treat and, as a group, patients in that study could thus also be
counted as being at risk of dropping out. Nevertheless, due to
the differences in population and methodology, the results
cannot be directly compared with ours.
Of note, completion of the program does not always indicate
treatment success in iCBTs. For instance, in iCBT for
depression, there seems to exist a subgroup of patients who
benefit rapidly and therefore prematurely discontinue the
treatment because it is subjectively perceived as unneeded [36].
In our study, in-depth analysis of reasons and exact time point
of dropout could not be performed due to having only 3
measurement points of depression.
Not all RCTs on STS showed the desired results, however. In
one depression study [24], patients received either email or STS
support added to iCBT, but with no differences in dropout rates.
Similarly, adherence did not improve with STS added to email
in a headache study by Andersson et al [37], nor did STS
demonstrate advantages over a clinician-moderated online
discussion forum in terms of adherence in an RCT on social
phobia from Titov and colleagues [38]. Interestingly enough,
all these negative studies included only unselected, self-referred
participants. In contrast, we focused only on physician-referred
patients (51/100, 51% of them from primary care) whose
initiation of iCBT was delayed by ≥2 weeks, which was
considered a risk of dropping out. These patients may have
experienced a special challenge in terms of adherence, since
unlike their counterparts in the majority of previous RCTs, they
may not always have originally been motivated to use iCBT;
they had no contact with a therapist or other research personnel
at screening (a contact that might have improved adherence),
and they showed a possible lack of engagement at the beginning
of iCBT.
The education level of supporting personnel may also matter,
but data on this issue are conflicting. In the negative-result
depression study by Lindner and colleagues [24], support
providers were psychology students, whereas our positive results
were achieved with support personnel being certified,
experienced clinical psychologists. Nevertheless, positive results
also emerged in the depression study of Gilbody and colleagues
[31], in which contact personnel comprised telephone support
workers. Moreover, STS personnel involved in other
(nondepression) conditions differed. Therapists were the support
providers in one positive-result OCD trial [32] and in one
negative headache trial [37], whereas technicians took this role
in the negative-result social phobia trial of Titov and colleagues
[38].
In psychotherapy research, researcher allegiance, a tendency to
favor certain preferred treatments, is widely discussed [39].
Treatment developers’ trials tend to yield better outcomes than
the later research performed by others, probably due to
researcher allegiance. One alternative explanation is that
developers themselves gain an advantage through their intense
clinical and research involvement with the treatment; they
become superior in treatment delivery [40]. Gilbody and
colleagues [31] attributed their poor outcomes and
adherence—results inferior to those demonstrated by treatment
developers—to differing means of service provision. Gilbody
and his group performed their trial within the Randomised
Evaluation of the Effectiveness and Acceptability of
Computerised Therapy trial, a large National Health
Service–funded program in which treatment provision was
decentralized. In contrast, in our setting, the developer of the
HUS-iCBT program, which was the Department of Psychiatry
of Helsinki University Hospital, was the only nationwide
centralized provider of both iCBT and the add-on STS. This
may explain our somewhat better-than-expected results.
The mechanism of the desirable effects of STS is uncertain.
These effects may result from increased therapist contact time,
from the telephone as the medium versus written contact only,
or from the proactivity of therapist-initiated scheduled contact.
What has been maintained is that increased therapist contact
time in iCBT for mood and anxiety disorders correlates strongly
with treatment outcome [41]. This association has not always
been detectable in reviews, however [24], and has been
considered true only up to a certain threshold [42]. Gilbody and
colleagues [31] did not describe their average STS time. The
STS time in the iCBT study on OCD [32] was 232 minutes
versus 178 minutes for the optional contact, which was markedly
more than the typical 90 to 150 minutes per patient in iCBT
trials [43]. In our study, average added telephone contact time
for the add-on STS intervention group was 73 minutes per
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patient (versus 2 minutes for the control group). Given the
average 55-minute therapist time per patient for HUS-iCBT,
SPS means a 2.4-fold increase in contact time. Neither the study
by Kenwright and colleagues [32] or by Gilbody and colleagues
[31] nor the present one has been a dose-finding trial. We were
unable to locate any dose-finding trials on the effects of contact
time in added STS in any iCBT program. It therefore remains
unclear whether those 54 additional minutes of STS time for
OCD or our 73 additional minutes for depression are optimal
in terms of adherence or symptomatic improvement in iCBT.
Nevertheless, the 2.4-fold increase in resource allocation when
weighted against health benefits achieved may be of interest to
administrative decision makers.
The telephone as a medium is one of the synchronous contact
modes, in contrast to asynchronous contact via written message
(usually referred to as minimal contact) in the majority of iCBT
studies. Furthermore, unlike text message, a telephone
conversation conveys nonverbal voice signals (such as intonation
and pausation). Since in these 2 studies [31,32] the control
groups received no text-based support, no conclusions can be
drawn on the specific role of the telephone as a medium.
Moreover, other RCTs comparing telephone support with email
support found no differences in treatment outcomes or dropout
rates [24,37,38]. The role of the voice contact in iCBTs and the
specific mechanisms of action therein remain poorly understood.
Limitations and Strengths
Our sample size was relatively small. Although between-group
differences were statistically significant, statistical power was
insufficient for subgroup analyses and hence for identification
of a subpopulation for optimal therapist resource allocation.
Due to selection of population (patients at risk for dropout in
everyday clinical practice), the dropout rate in our study was
expectedly high, with 76% (38/50) in the STS group and 94%
(47/50) in the control group dropping out, when dropout is
defined as those who did not finish the treatment in 6 months.
In addition, the patients did not have a strict deadline of 6
months, even though the measurements were conducted at that
point. Studies comparing iCBT programs with unselected
populations reported a 62% dropout rate in everyday clinical
practice and 15% to 25% in RCTs [29]. Our findings underline
the difficulties of maintaining adherence in routine clinical care
for digital health products that demonstrate impressive results
in clinical trials [44]. Nevertheless, the STS in this study showed
results comparable to an 82% dropout rate in earlier
observational studies on iCBT for depression with unselected
population [22].
Therapist effects in our study could not be ruled out, since 2 of
altogether 5 therapists treated 63 of the 100 (63%) patients. This
small number of therapists is, however, too small for reliable
assessment of possible therapist effects [45].
The effect of support may depend on the patient group [46]. We
defined the ≥14-day delay prior to the beginning of iCBT
treatment as a criterion of dropout risk based on clinical
experience, since, to the best of our knowledge, no clear-cut
criteria for such risk have yet been defined. This criterion might
fit only a certain subgroup of our patients, meaning that the
add-on STS intervention was applied for no reason also to a
not-at-risk subgroup. Understanding the reasons for patient
delay could help to sharpen this criterion, but in our study, data
as to the reasons were unavailable.
The HUS-iCBT with add-on STS required 77 minutes more
therapist time than did the HUS-iCBT as usual. Cost-benefit
analysis of STS was not a subject of this study, so our results
are insufficient to inform decision makers on whether to use
STS for patients at risk for dropout in routine clinical practice,
not to mention for patients at no such risk.
Future Research
Future research should explore in depth possible criteria for
those at risk for dropping out to discover optimal contact time
with larger populations. Add-on STS in other populations, such
as depressed patients who demonstrate no delay in initiation of
iCBT or patients with disorders other than depression, is worth
studying. Reasons for the delayed initiation of iCBT as well as
other predictors of poor adherence call for exploration.
Cost-benefit analysis could optimize the use of add-on STS.
Add-on STS provided by professional groups of a lower
educational level than that of our clinical psychologists also
demands exploration.
Our study employed STS added to text-based support, but STS
alone should also be a focus of research in populations at risk
of dropout to reveal the unconfounded effects of STS as such.
Comparison of STS with other support media, such as voice
messages (asynchronous contact mode but enriched with
nonverbal voice modulations) or chat (synchronous contact but
devoid of nonverbal voice modulations), can yield new insights
into both the mechanism of action of STS and the practical
means to optimize cost benefits of support.
Possible therapist effects should be explored in further iCBT
studies with a greater number of therapists with equal caseloads
providing STS.
Conclusion
STS added to the usual iCBT appears to improve both adherence
and clinical symptomatology in patients with depression at risk
for dropout from iCBT, but more research is required to optimize
its use.
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